"We appreciate efforts to bring a new perspective into the P&T committee process that represents the experience of patients and people with disabilities that are impacted by formulary decisions," wrote PIPC Chair Tony Coelho. "We urge you to consider final requirements that more directly call for a patient representative, as well as a process for partnership with organizations representing patients and people with disabilities and engagement of impacted patients and people with disabilities."
pipc_comment_nbpp.pdf |